Insider Transactions Reported by 14 Insiders of Eloxx Pharmaceuticals, Inc.

Location
Arlington, MA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Eloxx Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pontifax Management 4 G.P. (2015) Ltd. 10%+ Owner $443,946 13 May 2021
Sumit Aggarwal Director $43,200 24 Jan 2025
Daniel E. Geffken Interim Cfo $36,000 29 Nov 2021
Neil S. Belloff Coo, General Counsel &Corp Sec $30,293 30 Jul 2021
Steven D. Rubin Director $5,400 24 Jan 2025
Alan Edmund Walts Director $5,400 24 Jan 2025
Lindsay Androski Director $5,400 24 Jan 2025
Tomer Kariv Director 30 Jan 2023
Gadi Veinrib Director 15 Jun 2022
Zafrira Avnur Director 15 Jun 2022
Jasbir Seehra Director 15 Jun 2022
Vijay Modur Head Of R&D 25 Jan 2023
Rajesh B. Parekh Director 15 Jun 2022
Ran Nussbaum Director 15 Jun 2022

Recent Insider Transactions by Companies or Individuals for Eloxx Pharmaceuticals, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.